Papers
6
Total Citations
362
H-Index
4
About
Anand Mahadevan is a leading radiation oncologist whose work has fundamentally advanced the use of stereotactic body radiotherapy (SBRT) for challenging and often inoperable cancers. His research focuses on pushing the boundaries of precision radiation, particularly for tumors of the pancreas, pelvis, and skull base. Mahadevan’s most impactful contribution is his pioneering work on combining SBRT with gemcitabine for locally advanced pancreatic cancer, a study cited over 230 times that established a new, more effective treatment paradigm for this notoriously difficult disease. He has also been instrumental in refining the technical aspects of SBRT, including robotic respiratory tracking to manage organ motion and deformation during treatment, ensuring accurate dose delivery. His investigations into SBRT reirradiation for pelvic recurrences from colorectal cancer and hypofractionated stereotactic radiotherapy for benign skull base tumors have provided crucial evidence for using high-dose radiation in previously treated or sensitive areas. With a career spanning over a decade of influential publications, Mahadevan’s work continues to shape clinical practice, offering curative-intent, non-invasive options for patients with complex tumors.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6